251 related articles for article (PubMed ID: 30718416)
21. Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens.
Stowell SR; Arthur CM; Mehta P; Slanina KA; Blixt O; Leffler H; Smith DF; Cummings RD
J Biol Chem; 2008 Apr; 283(15):10109-23. PubMed ID: 18216021
[TBL] [Abstract][Full Text] [Related]
22. Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions.
Sörme P; Kahl-Knutsson B; Huflejt M; Nilsson UJ; Leffler H
Anal Biochem; 2004 Nov; 334(1):36-47. PubMed ID: 15464951
[TBL] [Abstract][Full Text] [Related]
23. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells.
Patnaik SK; Potvin B; Carlsson S; Sturm D; Leffler H; Stanley P
Glycobiology; 2006 Apr; 16(4):305-17. PubMed ID: 16319083
[TBL] [Abstract][Full Text] [Related]
24. How galectins have become multifunctional proteins.
García Caballero G; Kaltner H; Kutzner TJ; Ludwig AK; Manning JC; Schmidt S; Sinowatz F; Gabius HJ
Histol Histopathol; 2020 Jun; 35(6):509-539. PubMed ID: 31922250
[TBL] [Abstract][Full Text] [Related]
25. Influence of protein (human galectin-3) design on aspects of lectin activity.
García Caballero G; Beckwith D; Shilova NV; Gabba A; Kutzner TJ; Ludwig AK; Manning JC; Kaltner H; Sinowatz F; Cudic M; Bovin NV; Murphy PV; Gabius HJ
Histochem Cell Biol; 2020 Aug; 154(2):135-153. PubMed ID: 32335744
[TBL] [Abstract][Full Text] [Related]
26. Glycodendrimers and Modified ELISAs: Tools to Elucidate Multivalent Interactions of Galectins 1 and 3.
Wolfenden M; Cousin J; Nangia-Makker P; Raz A; Cloninger M
Molecules; 2015 Apr; 20(4):7059-96. PubMed ID: 25903363
[TBL] [Abstract][Full Text] [Related]
27. Assembly, organization and regulation of cell-surface receptors by lectin-glycan complexes.
Elola MT; Blidner AG; Ferragut F; Bracalente C; Rabinovich GA
Biochem J; 2015 Jul; 469(1):1-16. PubMed ID: 26173257
[TBL] [Abstract][Full Text] [Related]
28. The third dimension of reading the sugar code by lectins: design of glycoclusters with cyclic scaffolds as tools with the aim to define correlations between spatial presentation and activity.
Murphy PV; André S; Gabius HJ
Molecules; 2013 Apr; 18(4):4026-53. PubMed ID: 23558543
[TBL] [Abstract][Full Text] [Related]
29. Altering the Modular Architecture of Galectins Affects its Binding with Synthetic α-Dystroglycan O-Mannosylated Core M1 Glycoconjugates In situ.
Villones LL; Ludwig AK; Kikuchi S; Ochi R; Nishimura SI; Gabius HJ; Kaltner H; Hinou H
Chembiochem; 2023 Jul; 24(14):e202200783. PubMed ID: 36892311
[TBL] [Abstract][Full Text] [Related]
30. Cell-type-specific expression of murine multifunctional galectin-3 and its association with follicular atresia/luteolysis in contrast to pro-apoptotic galectins-1 and -7.
Lohr M; Kaltner H; Lensch M; André S; Sinowatz F; Gabius HJ
Histochem Cell Biol; 2008 Sep; 130(3):567-81. PubMed ID: 18597104
[TBL] [Abstract][Full Text] [Related]
31. Synthetic Mucin-Like Glycopeptides as Versatile Tools to Measure Effects of Glycan Structure/Density/Position on the Interaction with Adhesion/Growth-Regulatory Galectins in Arrays.
Artigas G; Hinou H; Garcia-Martin F; Gabius HJ; Nishimura SI
Chem Asian J; 2017 Jan; 12(1):159-167. PubMed ID: 27873468
[TBL] [Abstract][Full Text] [Related]
32. Advanced high-affinity glycoconjugate ligands of galectins.
Hovorková M; Červený J; Bumba L; Pelantová H; Cvačka J; Křen V; Renaudet O; Goyard D; Bojarová P
Bioorg Chem; 2023 Feb; 131():106279. PubMed ID: 36446202
[TBL] [Abstract][Full Text] [Related]
33. Unraveling functional significance of natural variations of a human galectin by glycodendrimersomes with programmable glycan surface.
Zhang S; Moussodia RO; Vértesy S; André S; Klein ML; Gabius HJ; Percec V
Proc Natl Acad Sci U S A; 2015 May; 112(18):5585-90. PubMed ID: 25902539
[TBL] [Abstract][Full Text] [Related]
34. Human chimera-type galectin-3: defining the critical tail length for high-affinity glycoprotein/cell surface binding and functional competition with galectin-1 in neuroblastoma cell growth regulation.
Kopitz J; Vértesy S; André S; Fiedler S; Schnölzer M; Gabius HJ
Biochimie; 2014 Sep; 104():90-9. PubMed ID: 24909114
[TBL] [Abstract][Full Text] [Related]
35. Enzymatic synthesis of non-natural trisaccharides and galactosides; Insights of their interaction with galectins as a function of their structure.
Porciúncula González C; Cagnoni AJ; Mariño KV; Fontana C; Saenz-Méndez P; Irazoqui G; Giacomini C
Carbohydr Res; 2019 Jan; 472():1-15. PubMed ID: 30428394
[TBL] [Abstract][Full Text] [Related]
36. Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways.
Bi S; Earl LA; Jacobs L; Baum LG
J Biol Chem; 2008 May; 283(18):12248-58. PubMed ID: 18258591
[TBL] [Abstract][Full Text] [Related]
37. Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin-glycan specificities in a natural context.
Nielsen MI; Stegmayr J; Grant OC; Yang Z; Nilsson UJ; Boos I; Carlsson MC; Woods RJ; Unverzagt C; Leffler H; Wandall HH
J Biol Chem; 2018 Dec; 293(52):20249-20262. PubMed ID: 30385505
[TBL] [Abstract][Full Text] [Related]
38. Varied expression and localization of multiple galectins in different cancer cell lines.
Satelli A; Rao PS; Gupta PK; Lockman PR; Srivenugopal KS; Rao US
Oncol Rep; 2008 Mar; 19(3):587-94. PubMed ID: 18288388
[TBL] [Abstract][Full Text] [Related]
39. Protein subtype-targeting through ligand epimerization: talose-selectivity of galectin-4 and galectin-8.
Oberg CT; Blanchard H; Leffler H; Nilsson UJ
Bioorg Med Chem Lett; 2008 Jul; 18(13):3691-4. PubMed ID: 18539029
[TBL] [Abstract][Full Text] [Related]
40. Regioselective 3-O-Substitution of Unprotected Thiodigalactosides: Direct Route to Galectin Inhibitors.
Vašíček T; Spiwok V; Červený J; Petrásková L; Bumba L; Vrbata D; Pelantová H; Křen V; Bojarová P
Chemistry; 2020 Aug; 26(43):9620-9631. PubMed ID: 32368810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
